{"cmr":"nl-cm-kg/XAMS/NL0010391025","since":null,"total":58,"cursor":0,"limit":50,"next_cursor":50,"events":[{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-11-06","event_type":"agm_egm","title":"Azerion publishes the Notice of its Extraordinary General Meeting of 18 December 2026 regarding the appointment of new members to the Management and Supervisory Boards","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2501-01197","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"25xWp-K9UElufHA-eSX4cPynRHDeZMi9D9Wdab5oTbUnoA26d-2kQ4Erl2SYOdTl719UCTm3cr90_uKyIjniBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-11-06","event_type":"newswire_release","title":"MHRA approves Pharming’s Joenja® (leniolisib) as first","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/11/06/3397310/0/en/mhra-approves-pharming-s-joenja-leniolisib-as-first-treatment-specifically-for-children-with-apds-in-the-u-k.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"_X7Eqz3nOOCuYgCdDoFT5_90LGvKmlHA1ZLjUEmqSIkFtD_WUTSdEC08P9dRIpxyzVDA_tBRgRrDpqYJt1NHDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-10-27","event_type":"results","title":"Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2610-01349","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"cp9xqa62wAkRmBZa8T-X5HGn1_mksXG2NS5wGJ1-FLWGDK2FzAK2o8sWFKCFRdyKj0IG_pYMyIjOrgoBh6eyCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-10-27","event_type":"results","title":"Pharming Group reports third quarter 2026 financial","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/27/3388693/0/en/pharming-group-reports-third-quarter-2026-financial-results-strong-revenue-growth-joenja-apds-expansion-and-cvid-topline-data-in-november.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RcbNQiOwWrPxX-_SFcdImPcXrVWSZMT27cr5nnSS-gLQtTt69mFiLW36bSE-Z2wFwzAFkmYcwjqmu87bR03ABQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-10-27","event_type":"results","title":"Pharming Group reports third quarter 2026 financial results","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/Resource/Download/0cb2b486-3c7d-4d09-a25a-6b26c15830ce","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"EXr3q1YVaFIc9Xw7FN5-bx2C7qYYlHpSV2oWDgwNks8b0rUfSw8b7GfGu0FEXd7dji_-r1ldxZYovcYsF7nYAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-10-22","event_type":"results","title":"Pharming Group announces third quarter 2026 revenues above market expectations","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2610-01134","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"M7qfOk_bttlLHykPBGLzleeP6d5_8f_vuWKRqhhc7wmueU5NtOoSMpd_GWzqpeCM4lVOtMNjjxo6CgNSx5UmCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-10-22","event_type":"results","title":"Pharming Group announces third quarter 2026 revenues above","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/22/3386017/0/en/pharming-group-announces-third-quarter-2026-revenues-above-market-expectations.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ZZg8vDBjABtJm1eX5uDlDx9KuSLUDTHkat7z63emoDBbT6tJVTuCun4BuAOpPWQ_TFq6TUtML1KioMykaOnKCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-10-14","event_type":"ad_hoc","title":"Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2610-00747","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"HvsBFZIIhg7qBWfoG2ptYqRSDrQp6HR0NANBAswkOkFktnYSjxFhyOSq4YiOZFdqEhOVzB1gCAHLLQKWzt1iBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-09-29","event_type":"ad_hoc","title":"Pharming announces CEO transition","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2609-01570","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Mj11Q2un-fJpFZB1uwHme4ZSHziRidtfhCgGAm5CFfEvG3ggY9fV50QnAtRB5-4fkIp0FNc1dA2UHS9HfZJkDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-09-29","event_type":"newswire_release","title":"Pharming announces CEO transition","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/29/3370380/0/en/pharming-announces-ceo-transition.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"2Ci6qvaiyhIFxKVRAQN9GXsETloZb9ZlQphxedEJPAdSLsvheM9nkUQ5cY2rrshtobIpGzhCe3lu0I6ImntMCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-09-25","event_type":"ad_hoc","title":"Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2609-01451","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"M258jQ93usXOcdgZZ_q-lGV8gqDzig5xoUJ78T0lcGJcJ1Mq0IfngO12V8-WUnUOcnnsmTVlm3PpUpCphgVeDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-09-11","event_type":"ad_hoc","title":"FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2609-00739","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"201vBenxNOvBkR7Zyik4X8pq7fAPTFTXOKpYrA5CCHT_jXJGaN6XXLyHOmzxMbJeojfenP9XD8ROJbrNXZc0Dw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-09-11","event_type":"newswire_release","title":"[PDF] FDA approves Pharming's Joenja® as first treatment for children ...","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/Resource/Download/d4526c5c-8a20-40b3-88cf-0c4b0009d64d","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"DFKVhM-5TPxpVp9DFF5PRVL9hrqA5s1_G5CYhO6eLCTConzzG29Ew5kMWu0F6-d8BfZ1739jRHgtyXJXkdzeCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-09-09","event_type":"newswire_release","title":"Pharming Group to participate in September investor","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/09/3358304/0/en/pharming-group-to-participate-in-september-investor-conferences.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"mQn3JpLd4jA-N468dUg6ni4Bn8nlk91NphbTpEvG_uqpn7k7Lm-59y4ipB-p_OmvpeZKk4rxHMkAzbfdQtVkAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-08-13","event_type":"ad_hoc","title":"Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2608-00576","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"H5pCzRytiMztPFdt_ZPC3IlzxW-wvSOyCtsJu6-onZ8hQpP9PqAFb2HrMTE3bWUKsY1aWhe-lRdc-WtdfE3qDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-08-06","event_type":"newswire_release","title":"Securities Fraud Investigation Into Pharming Group N.V. (PHAR ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260806914235/en/Securities-Fraud-Investigation-Into-Pharming-Group-N.V.-PHAR-Announced-Shareholders-Who-Lost-Money-Urged-To-Contact-Glancy-Prongay-Wolke-Rotter-LLP-a-Leading-Securities-Fraud-Law-Firm","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"vwJrdRsHIgOD6jw-cUe50VWJgAJfGlQtncPa_JfmJssQtv9oT_M6ytKjr_LOEKHPwP4fvgaJSRhfnyytnztMDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-08-06","event_type":"newswire_release","title":"Pharming Group N.V. (PHAR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260806789693/en/Pharming-Group-N.V.-PHAR-Shareholders-Who-Lost-Money-Contact-Law-Offices-of-Howard-G.-Smith-About-Securities-Fraud-Investigation","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"FxucnIp2TLPdR0vcx4VuOiyZdluLLEylsRfj0qTINUIrwQxujGh5sBV2jT0aY5aLBGhDaUDJwCPFOhNluFtqAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-08-05","event_type":"newswire_release","title":"Securities Fraud Investigation Into Pharming Group N.V. (PHAR ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260805570152/en/Securities-Fraud-Investigation-Into-Pharming-Group-N.V.-PHAR-Announced-Shareholders-Who-Lost-Money-Urged-To-Contact-The-Law-Offices-of-Frank-R.-Cruz","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"VxErV9T2-h7zZfPhBlrKXbmVFkoV2rVBQPc3SIO8ybsJ781RGypyTcnFLWFblxFa36xwHUZzBXH__36IJayqDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-07-30","event_type":"ad_hoc","title":"Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2607-01840","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"0hAFA9rWKNrruZQ6zzfYwFZkXI78hF35aSSGoEVKuhGf-mmevv2r4BB7sW7kX_B2YmZKYdD6LNrkaYrrO5_IBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-07-30","event_type":"results","title":"2026","category":"financial reporting","language":"nl","wire":"AFM","source":"AFM register — financial reporting","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/financiele-verslaggeving/details?id=A2510-03937","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: financial reporting; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"m9ZDyoxPijwoesJB0LB5aDo9w7MFRziAegUvDz1NI1CClPKiFH08QMfkSO4iHo6VM9kHy3B03iSj10ZaEniDCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-07-16","event_type":"results","title":"Pharming Group to report second quarter and first half 2026","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/07/16/3328224/0/en/pharming-group-to-report-second-quarter-and-first-half-2026-financial-results-and-provide-business-update-on-july-30.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"sCNj--DCSPits65AeG0LkAV8fxdFiauX3dyrOfgQ5i5wYBZNbJBR7p-arMKWNhLlc5JFKZK6-fqA_kNoXr69DA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-06-04","event_type":"ad_hoc","title":"Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2606-00241","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Np8Vz-PX9WjfGHHUaky2oiDVVHmUIYURr3WyWMIpjDwmCbByo43w402YFGhHqRXE7Gu9y_TDKiatcAks3llHDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-06-02","event_type":"newswire_release","title":"Pharming Group to participate in Fireside Chat at 2026","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/06/02/3304847/0/en/pharming-group-to-participate-in-fireside-chat-at-2026-jefferies-global-healthcare-conference-in-new-york.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"TZtJmz14ITHS0pVr3jkrDlsws8qSNaVYPnTDoVuRg5UxaTKIgBWolWOGwSgc6v6-mfmV5E7GUBycUA3OBlzKAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-05-28","event_type":"agm_egm","title":"Pharming Group announces results of 2026 Annual General Meeting of Shareholders","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2605-02009","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ohAOBSS3h3oCxCUEQts17xkM9nvqAMPAJeM5cYE4dxyklkpwiYjjRwgcTXozZOpQUAnBh8t5uRDuerBMmM7fCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-05-28","event_type":"directors_dealings","title":"R. Peters","category":"directors' and supervisory board transactions","language":"nl","wire":"AFM","source":"AFM register — directors' and supervisory board transactions","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/bestuurders-commissarissen/details?id=194918","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: directors' and supervisory board transactions; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xnB9t_BENyFNJhTwRcmbgz_za4vK8Dm-CtIZOUJeqDkgimGhcZlSgLCwEhmB63up270gjNCGORH-Ibe5pjwSBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-05-28","event_type":"directors_dealings","title":"B. Yanni","category":"directors' and supervisory board transactions","language":"nl","wire":"AFM","source":"AFM register — directors' and supervisory board transactions","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/bestuurders-commissarissen/details?id=194919","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: directors' and supervisory board transactions; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"gYdXqcoVH-F0W_wdSJrRhfYHXGn1CuqZqtlNuvz4jzuQGdiFURNDQC_-sU202SutPb-C6hL1z_nTdxq7oWXgDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-05-28","event_type":"directors_dealings","title":"L. Kruimer","category":"directors' and supervisory board transactions","language":"nl","wire":"AFM","source":"AFM register — directors' and supervisory board transactions","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/bestuurders-commissarissen/details?id=194920","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: directors' and supervisory board transactions; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"A6Rbk8S0LHk1Nq6oOrwQ7V75njYPWM25JSbDARiWrM9mFqLfHTzzpJ5fDde9-TycchDe8576oGHQHQJRjwmkBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-05-28","event_type":"directors_dealings","title":"J. van der Meijs","category":"directors' and supervisory board transactions","language":"nl","wire":"AFM","source":"AFM register — directors' and supervisory board transactions","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/bestuurders-commissarissen/details?id=194921","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: directors' and supervisory board transactions; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XwORl-jw_2EFyqFsb2wOKqyhQHmGWZd06pvNpIextdoDNGgf7fDmV9rxcWWfh9gXbDHffaDa-UcQ8YFpr-2lCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-05-28","event_type":"directors_dealings","title":"M. Pykett","category":"directors' and supervisory board transactions","language":"nl","wire":"AFM","source":"AFM register — directors' and supervisory board transactions","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/bestuurders-commissarissen/details?id=194922","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: directors' and supervisory board transactions; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PKrty2qPgWojb3Fd5rZWEdH9VneNS4lZHW5f3gBgKASY14OIUWLZfjjw0_fC-rcN795NsbKAyoZ8im0XUnG_DQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-05-28","event_type":"directors_dealings","title":"E. Sullivan","category":"directors' and supervisory board transactions","language":"nl","wire":"AFM","source":"AFM register — directors' and supervisory board transactions","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/bestuurders-commissarissen/details?id=194923","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: directors' and supervisory board transactions; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1xNkOtd_uR0OeuqtpzNXOlov1PZFcq6J8Me5zbwglYIkR9DZMT5_kO4E5NRrfIVTnqawLydnrg0Yg_yxjZmqAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-05-22","event_type":"ad_hoc","title":"European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2605-01680","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"zhkiNrtaBtt0R7NCNakTzRMtfPgPQvTtUquXxGHu5snlaYr_B1iuQ0jhVXMUf0HO9usvk5ayxpcPocabYY_NCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-05-07","event_type":"newswire_release","title":"Pharming Group announces presentations at CIS 2026 Annual","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/05/07/3289580/0/en/pharming-group-announces-presentations-at-cis-2026-annual-meeting-including-leniolisib-pediatric-data-in-apds-and-clinical-experience-in-cvid-and-related-disorders.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"chEWsriUkYp6Md2OaHvUm1OcB0kK93d1hAezPbGFSfFhSrXNONwYgPjDiHo83fcNaZOoI-ERexGB0CRYvSfxBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-05-07","event_type":"results","title":"Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2605-00527","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5R7t4YT1LBdPTIfual73T4GAUP7-35MPrcth9dOzhp1EOUVbWEmwWFPm_qjwoVWPtEVzlAzRgCmKFf2uueEICQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-05-07","event_type":"results","title":"Pharming Group reports first quarter 2026 financial - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/05/07/3289568/0/en/pharming-group-reports-first-quarter-2026-financial-results-on-track-for-joenja-u-s-pediatric-label-expansion-and-launches-in-japan-and-europe-in-2026.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"BRIK2kqnc5SsPCUkIQn2T2jAg6sQfVM814KIQu08teeyDD7vfPmRQ2LATmSxx3q-F7B8ziaXlF8_O4EEnJrdCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-04-16","event_type":"agm_egm","title":"Pharming Group announces the 2026 Annual General Meeting of Shareholders","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2604-01090","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"UsI4NKLXczhIuP9X3PnXoudJifv9nZWUNIC-t_XSn-NgInqlmgnNiyQlLhcIjdXbPleBHf9mNSBpZs36DELMCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-04-16","event_type":"agm_egm","title":"Pharming Group announces the 2026 Annual General Meeting of","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/04/16/3275035/0/en/pharming-group-announces-the-2026-annual-general-meeting-of-shareholders.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Ym84J_dj_-109KJ-vRkVLG1XYgGZM8-MxtkPkHlhTp7SJIfG8mlIPYZpLfKzwAOe6kB2fFGecw6Sll3efnDlBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-04-02","event_type":"newswire_release","title":"Pharming Group announces the filing of its 2025 Annual","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://globenewswire.com/news-release/2026/04/02/3267115/0/en/pharming-group-announces-the-filing-of-its-2025-annual-report-and-form-20-f.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PK7ubRZBqCn3ynip1LTJmqWf1vUG06TEPaCIxKJl3ybAGDuDGraT8RSTyq8yNMwuUNOgsKm87DycPJdfcQVxDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-04-02","event_type":"newswire_release","title":"Pharming Group announces the filing of its 2025 Annual","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/04/02/3267115/0/en/pharming-group-announces-the-filing-of-its-2025-annual-report-and-form-20-f.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"y9rSAWlqVNVjQGsD9JTxc-u3xnDoX2gDC-uHNJYiekxFXsCEUD1L5ITZFBDSBJzjew-8N3SFpqZmo7TN7iXaBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-04-02","event_type":"newswire_release","title":"Pharming Group announces the filing of its 2025 Annual","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/de/news-release/2026/04/02/3267115/0/en/Pharming-Group-announces-the-filing-of-its-2025-Annual-Report-and-Form-20-F.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"evu9BwsLHn45ppPlM3-10dpgwIGoGU9UZDbmSBI7uRTHSzijmg6Fos46QGdlJtIm0shuT8RGGAdUkqMuzguFCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-04-02","event_type":"newswire_release","title":"Pharming Group announces the filing of its 2025 Annual","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/fr/news-release/2026/04/02/3267115/0/en/Pharming-Group-announces-the-filing-of-its-2025-Annual-Report-and-Form-20-F.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"vgn4HsLaKbHoqisPSxXJYosDrz2PnW_UCHTF1hCpqqvNLOfgAak03P_xHlUHwSUEfdaB9W7HOvgcwRNEsynEDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-04-02","event_type":"results","title":"Pharming Group announces the filing of its 2025 Annual Report and Form 20-F","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2604-00105","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"x96IaRCMfed4riT5KxO9pa7BdZHUdq5zhYOz3VY79nIo0vXbzTGohkKGDBFixEoxlVGlQ4OLGcrCu7tiggnhCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-04-02","event_type":"results","title":"2025","category":"financial reporting","language":"nl","wire":"AFM","source":"AFM register — financial reporting","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/financiele-verslaggeving/details?id=A2510-03655","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: financial reporting; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"KgY8OPaCSKUf5ZLowNwhobEmn2XAS5D-t9ZrpZUdvQndXb4yWFtCJKRIobOBRgiV2ad1mlGm8_EF2vggVJ4BBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-03-27","event_type":"ad_hoc","title":"Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2603-01873","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"k1S7fsuCcbJ4x6L8cVSphNXgVgKDjJACtlYhReTzMtjzgb2Ebhnj0BYtEUiP1qx69qrsZEVgUA3gfHRwCYNiDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-03-24","event_type":"ad_hoc","title":"Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2603-01470","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9R4Z7_mzAi8VG262kbdWcdfX6jQ4BQJSpjeJqtfP7rf3ugZ8L8WfnsFBH3O4Vu2X5Yj7ZBJ94lQLigd6iQPEBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-03-24","event_type":"newswire_release","title":"Pharming Group announces approval of Joenja® (leniolisib)","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/03/24/3260947/0/en/pharming-group-announces-approval-of-joenja-leniolisib-in-japan-for-the-treatment-of-apds-in-patients-aged-4-years-and-older.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"oLFbTlfW0416VofVGdLrHeLc5R5tgJOZogg441avw0PlpxHpjyhji_dVkYq_tX-vvT1nQ1M2O50OUJJJlTq_Bg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-03-12","event_type":"directors_dealings","title":"F. Chouraqui","category":"directors' and supervisory board transactions","language":"nl","wire":"AFM","source":"AFM register — directors' and supervisory board transactions","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/bestuurders-commissarissen/details?id=189920","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: directors' and supervisory board transactions; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"o9juAfFfqYSGSYZ07pWOP2jX-T7bp3IEpR8HJf_pA0Rt3pqIRvgfNZbRkLf3q7vFOo7N7fuFWiHmY_-xpDI9Cw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-03-12","event_type":"results","title":"Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2603-00672","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"QcNzi4iwRTjxlDiQHCq2mx6g-s2cz4U-HxXIhtC40AEj--FoiH1oX4uU8ZnoG9I3fJyjXlym9aJ9dGe_QoxFBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-02-03","event_type":"ad_hoc","title":"Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day","category":"inside information","wire":"AFM","source":"AFM register — inside information","url":"https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2602-00123","read_by":"AFM notification register (afm.nl, per issuer keyword)","detail":"register: inside information; issuer as registered: Pharming Group N.V.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NoOnapXUItr99C8b8x1QaZ1gkhzg-mWtQcG7jzisk_TXrf-2QqFUWUV0COXzruAYtZeR9rhDlzFYlLGstEnQDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-02-03","event_type":"ad_hoc","title":"Pharming Group announces 2026 financial guidance and","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/02/03/3230713/0/en/Pharming-Group-announces-2026-financial-guidance-and-highlights-rare-disease-pipeline-at-Investor-Day.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"FxDZNqJoO-15f9FvifO-6zdiTObJG6n1l8m91nN7cyLa2nLnKjAds53wyia-SqrHLUdqzBln8R7VeLTHT1TGBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"nl-cm-kg/XAMS/NL0010391025","date":"2026-02-03","event_type":"ad_hoc","title":"Pharming Group announces 2026 financial guidance and","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/fr/news-release/2026/02/03/3230713/0/en/Pharming-Group-announces-2026-financial-guidance-and-highlights-rare-disease-pipeline-at-Investor-Day.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"dkbOP7KKZrCR4L-7oNILwIG4UaqN6bPFT_G7Ppj4k23beSU4XAfFJKBjiP6NuAWPgUIqNr595oivkDExsCXMDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}